Reading the crystal ball: Primary care implications while awaiting outcomes for multi-cancer early detection tests.
作者信息
Lin Grace A, Phillips Kathryn A, Fendrick A Mark
机构信息
Division of General Internal Medicine, University of California, San Francisco, USA; Center for Translational and Policy Research on Precision Medicine, University of California, San Francisco, USA.
Center for Translational and Policy Research on Precision Medicine, University of California, San Francisco, USA.
出版信息
Healthc (Amst). 2023 Sep;11(3):100705. doi: 10.1016/j.hjdsi.2023.100705. Epub 2023 Aug 18.
Abstract
摘要
相似文献
1
Reading the crystal ball: Primary care implications while awaiting outcomes for multi-cancer early detection tests.展望未来：等待多癌早期检测测试结果时对初级保健的影响。
Healthc (Amst). 2023 Sep;11(3):100705. doi: 10.1016/j.hjdsi.2023.100705. Epub 2023 Aug 18.
2
Corrigendum to "Reading the crystal ball: Primary care implications while awaiting outcomes for multi-cancer early detection tests" [Healthcare 11 (2023) 100705].《解读水晶球：等待多癌早期检测测试结果时对初级保健的影响》勘误 [《医疗保健》11 (2023) 100705]
Healthc (Amst). 2024 Dec 11:100755. doi: 10.1016/j.hjdsi.2024.100755.
3
Multi-cancer Early Detection Tests, Primary Care, and Shared Decision Making.多癌早期检测测试、初级保健与共同决策
Ann Intern Med. 2023 May;176(5):718-720. doi: 10.7326/M23-0067. Epub 2023 Apr 11.
4
Multi-Cancer Early Detection: The New Frontier in Cancer Early Detection.多癌种早期检测：癌症早期检测的新前沿。
Annu Rev Med. 2024 Jan 29;75:67-81. doi: 10.1146/annurev-med-050522-033624. Epub 2023 Sep 20.
5
Are we ready? assessing effectiveness and implementation of cancer control strategies in primary care: a comprehensive review of systematic reviews.我们准备好了吗？评估初级保健中癌症控制策略的有效性和实施情况：系统评价的综合回顾。
Fam Pract. 2025 Feb 7;42(2). doi: 10.1093/fampra/cmae078.
6
Multi-cancer early detection tests for general population screening: a systematic literature review.用于普通人群筛查的多癌早期检测测试：一项系统文献综述
Health Technol Assess. 2025 Jan;29(2):1-105. doi: 10.3310/DLMT1294.
7
Perspectives of primary care providers regarding multicancer early detection panels.初级保健提供者对多癌种早期检测面板的看法。
Einstein (Sao Paulo). 2024 Aug 23;22:eAO0771. doi: 10.31744/einstein_journal/2024AO0771. eCollection 2024.
8
Multi-cancer early detection tests: Attributes for clinical implementation.多癌早期检测测试：临床应用的属性
Cancer Biomark. 2025 Feb;42(2):18758592241297849. doi: 10.1177/18758592241297849. Epub 2025 Apr 2.
9
A manifesto for improving cancer detection: four key considerations when implementing innovations across the interface of primary and secondary care.提高癌症检测水平的宣言：在初级保健和二级保健界面实施创新时的四个关键考虑因素。
Lancet Oncol. 2024 Aug;25(8):e388-e395. doi: 10.1016/S1470-2045(24)00102-5. Epub 2024 Jun 4.
10
Efforts in fighting against cancer in Croatia have to be focused on the primary health care.克罗地亚抗击癌症的工作必须聚焦于初级卫生保健。
Coll Antropol. 2008 Sep;32(3):709-24.
引用本文的文献
1
Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in Solutions.美国癌症基因组学的实施：支付方及其他利益相关者对挑战的看法以及支付方在解决方案中的作用
JCO Precis Oncol. 2025 Feb;9:e2400822. doi: 10.1200/PO-24-00822. Epub 2025 Feb 28.
本文引用的文献
1
CMS Coverage With Evidence Development-Challenges and Opportunities for Improvement.医疗保险与证据发展覆盖范围——改进的挑战与机遇
JAMA Health Forum. 2022 Sep 2;3(9):e223061. doi: 10.1001/jamahealthforum.2022.3061.
2
Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests.患者对多癌种早期检测（MCED）筛查测试的偏好。
Patient. 2023 Jan;16(1):43-56. doi: 10.1007/s40271-022-00589-5. Epub 2022 Jul 18.
3
Changes in Cancer Screening in the US During the COVID-19 Pandemic.美国在 COVID-19 大流行期间癌症筛查的变化。
JAMA Netw Open. 2022 Jun 1;5(6):e2215490. doi: 10.1001/jamanetworkopen.2022.15490.
4
Collaboration and Shared Decision-Making Between Patients and Clinicians in Preventive Health Care Decisions and US Preventive Services Task Force Recommendations.患者与临床医生在预防保健决策中的协作和共同决策，以及美国预防服务工作组的建议。
JAMA. 2022 Mar 22;327(12):1171-1176. doi: 10.1001/jama.2022.3267.
5
Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access.多癌种筛查检测：为支付方覆盖范围和患者可及性考虑因素做准备和应对。
Health Aff (Millwood). 2022 Mar;41(3):383-389. doi: 10.1377/hlthaff.2021.01316.
6
Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance.美国商业保险和医疗保险覆盖的成年人接受非侵入性结直肠癌筛查后行结肠镜检查的自付费用。
JAMA Netw Open. 2021 Dec 1;4(12):e2136798. doi: 10.1001/jamanetworkopen.2021.36798.
7
Barriers to utilization of three colorectal cancer screening options - Data from a national survey.三种结直肠癌筛查方法的使用障碍——来自一项全国性调查的数据
Prev Med Rep. 2021 Jul 29;24:101508. doi: 10.1016/j.pmedr.2021.101508. eCollection 2021 Dec.
8
Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.阿拉斯加原住民患者和医疗服务提供者对多靶点粪便DNA检测与结肠镜检查用于结直肠癌筛查的看法。
J Prim Care Community Health. 2019 Jan-Dec;10:2150132719884295. doi: 10.1177/2150132719884295.
9
Patterns and Trends in Cancer Screening in the United States.美国癌症筛查的模式和趋势。
Prev Chronic Dis. 2018 Jul 26;15:E97. doi: 10.5888/pcd15.170465.
10
Reducing racial and ethnic disparities in colorectal cancer screening is likely to require more than access to care.减少结直肠癌筛查中的种族和民族差异可能需要的不仅仅是获得医疗服务。
Health Aff (Millwood). 2012 Dec;31(12):2747-54. doi: 10.1377/hlthaff.2011.1290.
Zotero 插件